LifeSpan BioSciences, Inc. Announces Collaboration With Pfizer Inc. (PFE) To Develop Automated Pathology Systems
10/19/2005 5:12:54 PM
SEATTLE--(BUSINESS WIRE)--March 3, 2005--LifeSpan BioSciences Inc. today announced that they have entered into an agreement with Pfizer Inc (NYSE:PFE) to develop an automated pathology system for rapid and accurate evaluation of tissue specimens in preclinical studies.
comments powered by